Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
European Journal of Pharmacology|September 15, 2004
Within-session repeated acquisition behavior in rats as a potential model of executive functionHarlan E Shannon, Patrick L LoveEpilepsy & Behavior : E&B|December 19, 2006
Effects of antiepileptic drugs on learning as assessed by a repeated acquisition of response sequences task in ratsHarlan E Shannon, Patrick L LoveEpilepsy & Behavior : E&B|December 8, 2004
Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in ratsHarlan E Shannon, Patrick L LoveEpilepsy & Behavior : E&B|October 29, 2005
Effects of antiepileptic drugs on attention as assessed by a five-choice serial reaction time task in ratsHarlan E Shannon, Patrick L LoveNeuropharmacology|September 20, 2015
The effects in rats of lisdexamfetamine in combination with olanzapine on mesocorticolimbic dopamine efflux, striatal dopamine D2 receptor occupancy and stimulus generalization to a D-amphetamine cuePeter H Hutson, Helen L Rowley, James Gosden, et al.The Journal of Pharmacology and Experimental Therapeutics|September 6, 2008
The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the ratPaul A Ardayfio, Mark J Benvenga, Stephen F Chaney, et al.Bioorganic & Medicinal Chemistry Letters|February 6, 2013
Design, synthesis, and SAR of N-((1-(4-(propylsulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1Christopher L Cioffi, Mark A Wolf, Peter R Guzzo, et al.Neuropharmacology|July 8, 2008
Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areasKenneth W Perry, Julie F Falcone, Matthew J Fell, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulatorJunliang Hao, Veronique Dehlinger, Adam M Fivush, et al.Neuropharmacology|November 6, 2017
Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disordersRobert F Bruns, Stephen N Mitchell, Keith A Wafford, et al.Pageof 2